Weekly Adalimumab, an Effective Alternative for Refractory Uveitis in Children

J Clin Rheumatol. 2022 Jan 1;28(1):e301-e304. doi: 10.1097/RHU.0000000000001707.
No abstract available

MeSH terms

  • Adalimumab
  • Arthritis, Juvenile*
  • Child
  • Humans
  • Treatment Outcome
  • Uveitis* / diagnosis
  • Uveitis* / drug therapy

Substances

  • Adalimumab